Letter: thromboembolic and cardiovascular events with tofacitinib in ulcerative colitis-two cases in real world clinical practice. Authors' reply.

Saved in:
Bibliographic Details
Title: Letter: thromboembolic and cardiovascular events with tofacitinib in ulcerative colitis-two cases in real world clinical practice. Authors' reply.
Authors: Sandborn WJ; Division of Gastroenterology, University of California, San Diego, La Jolla, CA, USA., Panés J; Hospital Clínic de Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain., Sands BE; Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Reinisch W; Medical University of Vienna, Vienna, Austria., Su C; Pfizer Inc, Collegeville, PA, USA., Lawendy N; Pfizer Inc, Collegeville, PA, USA., Koram N; Pfizer Inc, New York, NY, USA., Fan H; Pfizer Inc, Collegeville, PA, USA., Jones TV; Pfizer Inc, Collegeville, PA, USA., Modesto I; Pfizer Inc, New York, NY, USA., Quirk D; Pfizer Inc, Collegeville, PA, USA., Danese S; Division of Gastroenterology, IBD Center, Humanitas University, Rozzano, Milan, Italy.
Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2020 Jun; Vol. 51 (11), pp. 1209-1210.
Publication Type: Letter; Comment
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1365-2036
DOI:10.1111/apt.15735